Aligos Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Aligos Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aligos Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aligos Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.7M | 172k | 9.80 |
| 2025-06-30 | $1.0M | 140k | 7.21 |
| 2025-03-31 | $1.2M | 141k | 8.25 |
| 2024-12-31 | $3.9M | 97k | 39.84 |
| 2024-09-30 | $553k | 64k | 8.66 |